undefined
EUTM file information

018383058

GAMMABODY


January 25, 2021

Trademark Summary

The trademark application GAMMABODY was filed by Lava Therapeutics N.V., a corporation established under the laws of the Kingdom of the Netherlands (the "Applicant"). The application was published for oppositions on May 26, 2021, and it was registered by office on September 2, 2021 without any oppositions.

It was designated 'Basic Application' for International Application 1633706 at the World Intellectual Property Organization (WIPO).

The application was filed in English (French was selected as the second language).

Appointment and Replacement of representative of the trademark registration was recorded on November 8, 2021. Change of name and address of the trademark registration was recorded on February 3, 2022. Change of name and professional address of the trademark registration was recorded on August 6, 2024.


Goods And Services

  • The mark was filed in class 1 with following description of goods:
    1. Antibodies for scientific and research use
    2. Libraries and collections of antibodies for scientific and research use
    3. Proteins, enzymes, diagnostic reagents, and chemical and biochemical preparations and substances for use in the manufacture of medicines.
  • The mark was filed in class 5 with following description of goods:
    1. Pharmaceutical preparations for T Cell therapy
    2. Pharmaceutical products for the prevention and treatment of cancer
    3. Immunotherapy products, namely, pharmaceutical preparations for the treatment of cancer, autoimmune diseases, and immunological disorders
    4. Biological preparations for the treatment of cancer autoimmune diseases, and immunological disorders
    5. Chemical and biochemical preparations and substances for medical purposes for treatment and/or diagnosis of cancer, autoimmune diseases and immunological disorders
    6. Antibodies and libraries of antibodies for medical purposes, for treatment and/or diagnosis of cancer, autoimmune diseases and immunological disorders.
  • The mark was filed in class 42 with following description of goods:
    1. Bio-technology and scientific services, namely, research, and production and development services relating to bio-technology and science, namely, antibodies, proteins and enzymes
    2. Pharmaceutical research and development
    3. Biological and bio-technology analysis services
    4. Scientific and medical laboratory services
    5. Biochemistry research services, namely, antibodies, protein and enzyme evolving services
    6. Biochemistry research services, namely, antibodies, protein and enzyme cataloging and library services.
  • The mark was filed in class 44 with Providing information about the treatment and/or diagnosis of cancer, autoimmune diseases and immunological disorders via a website.